Pharmesis International Ltd. announced unaudited consolidated earnings results for the second quarter and six months ended June 30, 2015. For the quarter, the company reported revenue of RMB 16,012,000 against RMB 14,552,000 a year ago. Profit from operations was RMB 817,000 against loss from operations of RMB 1,041,000 a year ago. Profit before tax was RMB 593,000 against loss before tax of RMB 356,000 a year ago. Profit for the period attributable to equity holders of the company was RMB 150,000 or 0.07 cents diluted per share against loss for the period attributable to equity holders of the company of RMB 119,000 or 0.06 cents diluted per share a year ago. Net cash flows used in operating activities were RMB 3,121,000 against net cash flows from operating activities of RMB 2,738,000 a year ago. Acquisition of property, plant and equipment was RMB 1,398,000 against RMB 185,000 a year ago.

For the six months, the company reported revenue of RMB 30,050,000 against RMB 27,986,000 a year ago. Profit from operations was RMB 80,000 against loss from operations of RMB 2,818,000 a year ago. Profit before tax was RMB 744,000 against loss before tax of RMB 1,482,000 a year ago. Profit for the period attributable to equity holders of the company was RMB 446,000 or 0.22 cents diluted per share against loss for the period attributable to equity holders of the company of RMB 578,000 or 0.29 cents diluted per share a year ago. Net cash flows used in operating activities were RMB 1,652,000 against net cash flows from operating activities of RMB 3,610,000 a year ago. Acquisition of property, plant and equipment was RMB 1,402,000 against RMB 268,000 a year ago. Group net asset value per ordinary share as on June 30, 2015 was 43.88 cents against 43.66 cents as on June 30, 2014. Company net asset value per ordinary share as on June 30, 2015 was 27.87 cents against 28.81 cents as on June 30, 2014.